SCHEMBL1795642

SCHEMBL1795642

CC(C)c1cc(C(O)C(F)(F)F)cc(C(C)C)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
GABRA1 P14867 6/20 0.48
GABRB2 P47870 3/20 0.48
GABRB1 P18505 5/20 0.47
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
FAAH O00519 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
GABRG2 P18507 1/20 0.40
PTGS1 P23219 1/20 0.40
SLC6A2 P23975 1/20 0.40
HTR2C P28335 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
HTR2B P41595 1/20 0.40
GABRA2 P47869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4775793 1.00 CA1 (0.50) CA1CA2GABRA1GABRB2GABRB1
SCHEMBL15539232 0.88 GABRA1 (0.44) CA1CA2GABRA1GABRB2GABRB1
SCHEMBL15539085 0.79 RECQL (0.41) GABRA1GABRB2LMNATSHRPTGS1
SCHEMBL15538701 0.79 RARG (0.34) GABRA1GABRB2GAAMAPT
SCHEMBL94533 0.75 GABRA1 (0.77) CA1CA2GABRA1GABRB2GABRB1
SCHEMBL3281421 0.74 GABRA1 (0.65) CA1CA2GABRA1GABRB2GABRB1
SCHEMBL7117823 0.74 GABRA1 (0.35) CA1CA2GABRA1GABRB2LMNA
Ammonia Solution, Strong SCHEMBL28098766 0.73 GABRA1 (0.74) CA1CA2GABRA1GABRB2GABRB1
SCHEMBL10966386 0.73 CA1 (0.64) CA1CA2GABRA1GABRB2GABRB1
SCHEMBL15539638 0.73 CA2 (0.33) CA2GABRA1GABRB1GAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951979-B2 2,4,6-trisubstituted phenols having anesthetic properties UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2011-05-31 US claimed
US-20100173997-A1 2,4,6-TRISUBSTITUTED PHENOLS HAVING ANESTHETIC PROPERTIES University of Iowa Research Foundatiion (US) 2010-07-08 US claimed
US-7678946-B2 2,4,6,-trisubstituted having anesthetic properties UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2010-03-16 US claimed
US-20080114073-A1 2,4,6,-Trisubstituted phenols having anesthetic properties UNIVERSITY OF IOWA RESEARCH FOUNDATION 2008-05-15 US claimed
WO-2008008498-A2 2, 4, 6-TRISUBSTITUTED PHENOLS HAVING ANESTHETIC PROPERTIES UNIVERSITY OF IOWA RESEARCH FDTN. (US) 2008-01-17 WO claimed
WO-2026102432-A1 HUMAN ANTIBODIES TO MARBURG VIRUS AND METHODS OF USE THEREFOR VANDERBILT UNIVERSITY (US) 2026-05-15 WO disclosed
WO-2025262636-A1 RNA BIOSENSOR AND GENE THERAPY CONTROLLER USING DISEASE-SPECIFIC CRYPTIC EXON RETENTION UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2025-12-26 WO disclosed
US-20250333517-A1 ENGINEERED GLYCOPROTEIN POPULATION AND USES THEREOF ROCK BIOMEDICAL INC (TW) 2025-10-30 US disclosed
WO-2025226309-A1 ENGINEERED GLYCOPROTEIN POPULATION AND USES THEREOF ROCK BIOMEDICAL INC. (TW) 2025-10-30 WO disclosed
US-20250333518-A1 ENGINEERED GLYCOPROTEIN POPULATION AND USES THEREOF ROCK BIOMEDICAL INC (TW) 2025-10-30 US disclosed
WO-2025226354-A1 ENGINEERED GLYCOPROTEIN POPULATION AND USES THEREOF ROCK BIOMEDICAL, INC. (TW) 2025-10-30 WO disclosed
CN-120192406-A Nanometer antibody for inhibiting infection of present Dibujiao type and zadil type Ebola viruses 中国医学科学院病原生物学研究所 2025-06-24 CN disclosed
US-7678946-B2 2,4,6,-trisubstituted having anesthetic properties UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2010-03-16 US disclosed
US-20080119566-A1 Hydrofluoroalkyl phenols having anesthetic properties UNIVERSITY OF IOWA RESEARCH FOUNDATION 2008-05-22 US disclosed
US-20080114073-A1 2,4,6,-Trisubstituted phenols having anesthetic properties UNIVERSITY OF IOWA RESEARCH FOUNDATION 2008-05-15 US disclosed
US-20080114073-A1 2,4,6,-Trisubstituted phenols having anesthetic properties UNIVERSITY OF IOWA RESEARCH FOUNDATION 2008-05-15 US disclosed
US-20080114073-A1 2,4,6,-Trisubstituted phenols having anesthetic properties UNIVERSITY OF IOWA RESEARCH FOUNDATION 2008-05-15 US disclosed
WO-2008008492-A2 HYDROFLUOROALKYL PHENOLS HAVING ANESTHETIC PROPERTIES UNIVERSITY OF IOWA RESEARCH FDTN. (US) 2008-01-17 WO disclosed
WO-2008008498-A2 2, 4, 6-TRISUBSTITUTED PHENOLS HAVING ANESTHETIC PROPERTIES UNIVERSITY OF IOWA RESEARCH FDTN. (US) 2008-01-17 WO disclosed
WO-2008008498-A2 2, 4, 6-TRISUBSTITUTED PHENOLS HAVING ANESTHETIC PROPERTIES UNIVERSITY OF IOWA RESEARCH FDTN. (US) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173997-A1 2,4,6-TRISUBSTITUTED PHENOLS HAVING ANESTHETIC PROPERTIES OPRK1, OPRM1, OPRL1 CA1 594/4885CA2 559/4885GABRA1 201/4885
US-20080114073-A1 2,4,6,-Trisubstituted phenols having anesthetic properties OPRK1, OPRM1, OPRD1 CA1 472/4885CA2 524/4885GABRA1 260/4885
US-20080119566-A1 Hydrofluoroalkyl phenols having anesthetic properties OPRL1, VHL, PPARG CA1 397/4885CA2 535/4885GABRA1 697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.